Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00112619
Recruitment Status : Terminated (Slow accrual and company withdrawing support to supply the drug)
First Posted : June 3, 2005
Last Update Posted : June 30, 2011
National Cancer Institute (NCI)
Information provided by:
Pediatric Brain Tumor Consortium

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : August 2010
  Study Completion Date : No date given